December 1, 2008
Drug manufacturer AstraZeneca PLC will reportedly have to provide the Food and Drug (FDA) Administration with more information about their new lung drug for infants before the agency will grant permission for it to be released onto the market. As reported by the Associated Press (AP), the company announced on Friday that the FDA […]
